Continuing Medical Education: Dyslipidemia CME: ABcomm, Inc.: Dyslipidemia Minifellowship: Complex Cases, Comprehensive Management: Philadelphia, PA: September 26, 2008
- By ABcomm, Inc.
- Published 07/9/2008
- Primary Care , Osteopathy , Health Nutrition , Nutrition , Multi-Speciality , Internal Medicine , General Medicine , Family Medicine , Endocrinology , Cardiology
- Unrated
Dyslipidemia Minifellowship: Complex Cases, Comprehensive Management
ABcomm, Inc.
ABcomm, Inc., with headquarters in Champaign, Illinois and Scottsdale, Arizona, has been involved in developing continuing education and training programs for health professionals since 1988.
Our primary focus is on accredited activities for physicians, pharmacists and nurse practitioners. ABcomm, Inc. is accredited by the American Council for Continuing Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Academy of Nurse Practitioners (AANP).
View All Postings by This Contributor.
Location: Hilton Philadelphia City Ave Philadelphia, PA
Course Directors/Instructors:
Daniel Rader, MD
Mike Miller, MD
Helene Glasberg, MD
Michael Ryan, MD
Cost: $30
Number of credits: 5.5
Detailed Description:
This half-day minifellowship is designed to provide physicians with evidence-based information on current issues and management strategies in the treatment of dyslipidemia. Through a live patient interview, lectures, case studies and open discussions, the small group format facilitates interaction between attendees and local and national opinion leaders. The goal of this Minifellowship is to enhance the knowledge of providers resulting in improved patient care. Topics have been selected based on extensive needs assessment data in the treatment of Dyslipidemia, including past participant surveys, clinical expert input, and practice guideline reviews.
Learning ObjectivesAs a result of attending this program, participants will be able to:
- Outline cholesterol targets and describe why many patients are not treated to goal.
- Discuss the role of elevated triglycerides and low high-density lipoprotein cholesterol in the overall patient profile, considering the impact of multiple lipid risk factors in cardiovascular disease risk.
- Review the accepted guidelines for treating multiple lipid parameters.
- Determine treatment options for the longitudinal care of dyslipidemia patients, including patients with diabetes, the metabolic syndrome, and other concomitant disorders.
- Analyze risk profiles of various medications alone and in combination, focusing on safety, tolerability and side-effect management.
- Describe how engaging patients in their own treatment goals leads to healthier lifestyle choices and medication adherence.
Spread The Word
Comments
No Comments Found.This review is the subjective opinion of a CME Networks site member or user and not of CME Networks, LLC.
CMENetworks.com Comment Policy: CMEnetworks.com encourages you to add a comment to this discussion. You may not post any unlawful, threatening, libelous, defamatory, obscene or other material that would violate the law. Please note that CMEnetworks.com may edit comments for clarity or to keep out questionable or off-topic material. All comments should be relevant to the post and remain respectful of other authors or commentors. By submitting your comment, you hereby give CMEnetworks.com the right, but not the obligation, to post, air, edit, exhibit, telecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying information via all forms of media now know or hereafter devised, worldwide, in perpetuity.
